Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS

Circulation Journal

Volumn 75, Issue 3, 2011, Pages 703-709

  Yu, Man Li ^a   Wang, Jia Feng ^a   Wang, Guo Kun ^a   You, Xiao Hua ^a   Zhao, Xian Xian ^a   Jing, Qing ^a   Qin, Yong Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Genes; Hypertension; Vessels

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; K RAS PROTEIN; LET 7A; LET 7D; LET 7F; LET 7I; MICRORNA; MICRORNA 1; MICRORNA 219; MICRORNA 34B; MICRORNA 378; MICRORNA 500; MICRORNA 92B; MICRORNA 98; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WISTAR KYOTO RAT;

ANIMALS; AORTA, THORACIC; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; MICRORNAS; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, INBRED SHR; RATS, INBRED WKY; SINCALIDE; TRANSFECTION;

EID: 79952338927     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0393     Document Type: Article

References (23)

1. Bornfeldt KE, Krebs EG. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 1999; 11: 465-477.
2. Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 2009; 73: 1731-1739.
3. Cho WC. OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60-66.
4. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, et al. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 2010; 29: 559-573.
5. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death Differ 2009; 16: 1590-1598.
6. Zhang C. MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease. Cell Cycle 2009; 8: 3469-3473.
7. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104: 476-487.
8. Louis WJ, Howes LG. Genealogy of the spontaneously hypertensive rat and Wistar-Kyoto rat strains: Implications for studies of inherited hypertension. J Cardiovasc Pharmacol 1990; 16(Suppl 7): S1-S5.
9. Uehara Y, Numabe A, Kawabata Y, Nagata T, Hirawa N, Ishimitsu T, et al. Rapid smooth muscle cell growth and endogenous prostaglandin system in spontaneously hypertensive rats. Am J Hypertens 1991; 10: 806-814.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 2001; 25: 402-408.
11. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
12. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67: 7713-7722.
13. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581-588.
14. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
15. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 2009; 284: 7903-7913.
16. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-677.
17. Büssing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008; 14: 400-409.
18. Hu WY, Han YJ, Gu LZ, Piano M, de Lanerolle P. Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats. Am J Hypertens 2007; 20: 53-61.
19. Passaquin AC, Schreier WA, de Vellis J. Gene expression in astrocytes is affected by subculture. Int J Dev Neurosci 1994; 12: 363-372.
20. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 812-819.
21. Ottaviano FG, Handy DE, Loscalzo J. Redox regulation in the extracellular environment. Circ J 2008; 72: 1-16.
22. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73: 615-621.
23. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor: Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 1995; 766: 416-430.